CWM, LLC
- SEC CIK
- 0001535847
- Latest filing
- May 14, 2026
KROS holding history
Keros Therapeutics, Inc. in every 13F filed by CWM, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KROS overviewAll 13F holders of KROSFull Q1 2026 holdings
- Shares (Q1 2026)
- 8,618
- Value
- $95.1K
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 8,618 | $95.1K | <0.1% | +4,786+124.9% | Added | Holders |
| Q4 2025 | 3,832 | $78.0K | <0.1% | −3,439−47.3% | Reduced | Holders |
| Q3 2025 | 7,271 | $115.0K | <0.1% | +2,271+45.4% | Added | Holders |
| Q2 2025 | 5,000 | $67.0K | <0.1% | +2,333+87.5% | Added | Holders |
| Q1 2025 | 2,667 | $27.0K | <0.1% | +2,641+10,157.7% | Added | Holders |
| Q4 2024 | 26 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q3 2024 | 26 | $2.00K | <0.1% | +1+4.0% | Added | Holders |
| Q2 2024 | 25 | $1.00K | <0.1% | +25 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −55−100.0% | Sold out | Holders |
| Q3 2023 | 55 | $2.00K | <0.1% | +22+66.7% | Added | Holders |
| Q2 2023 | 33 | $1.00K | <0.1% | +33 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −8−100.0% | Sold out | Holders |
| Q1 2022 | 8 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2021 | 8 | $0 | 0.0% | – | No prior filing | Holders |